Originally published on Health Industry Hub The management of New Zealand’s most common blood cancer, myeloma, is falling behind the rest of the world, putting lives at unnecessary risk of this incurable but treatable disease. This is a concerning finding of the Burden of Multiple Myeloma economics report released today by Myeloma New Zealand, who...Continue Reading

This story was originally published on RNZ  An advocate group is warning that New Zealanders are dying from a common blood cancer because they’ve been denied access to medicines. The Burden of Multiple Myeloma economics report, released by Myeloma New Zealand today, stated about 2500 people in New Zealand were living with myeloma, which affects plasma cells typically...Continue Reading